Life-prolonging drug for advanced ovarian cancer gets go-ahead in England
Elahere is first new drug for chemotherapy-resistant ovarian cancer to be approved by NHS for 20 years Hundreds of women with hard-to-treat ovarian cancer can now be offered a new life-prolonging treatment, after NHS England approved its introduction. It is the first new drug for resistant (…)
Site référencé: The Guardian (South&CentralAsia)
4585.jpg?width=140&quality=85&auto=format&fit=max&s=c670dca6242737506273e1890d21df10, 4585.jpg?width=460&quality=85&auto=format&fit=max&s=a466f1c99220e9a3274e03fede443528, 4585.jpg?width=700&quality=85&auto=format&fit=max&s=a02a8b8dadbd687ed14fa2a4f030a818
